Wuxi AppTec CoWUXIF 84 PB Ratio is 3.82 as of Jun. 28, 2026, which is 33% below its 10-year median of 5.71. GuruFocus rates WUXIF with a GF Score™ of 84/100 and a GF Value™ of $11.26 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 196 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks worse than 77.04% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-28), Wuxi AppTec Co's share price is $15.63. Wuxi AppTec Co's Book Value per Share for the quarter that ended in Mar. 2026 was $4.10. Hence, Wuxi AppTec Co's PB Ratio of today is 3.82.
The historical rank and industry rank for Wuxi AppTec Co's PB Ratio or its related term are showing as below:
WUXIF'
s PB Ratio Range Over the Past 10 Years
Min: 2 Med: 5.71 Max: 20.8
Current: 4.19
During the past 12 years, Wuxi AppTec Co's highest PB Ratio was 20.80. The lowest was 2.00. And the median was 5.71.
WUXIF's PB Ratio is ranked worse than 77.04% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.03
vs WUXIF: 4.19
During the past 12 months, Wuxi AppTec Co's average Book Value Per Share Growth Rate was 30.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 19.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 18.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 32.20% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Wuxi AppTec Co was 61.60% per year. The lowest was 16.00% per year. And the median was 35.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Wuxi AppTec Co PB Ratio Related Terms
Wuxi AppTec Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Wuxi AppTec Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Wuxi AppTec Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuxi AppTec Co PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Wuxi AppTec Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Wuxi AppTec Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Wuxi AppTec Co (WUXIF) has a PB Ratio of 3.82 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Wuxi AppTec Co and its competitors. This is 33% below median its historical median of 5.71. Over the past decade, Wuxi AppTec Co's PB Ratio has ranged from 2.00 to 20.80. According to the industry distribution chart, Wuxi AppTec Co ranks #151 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 77%.
Is Wuxi AppTec Co's PB Ratio too high?
Wuxi AppTec Co's current PB Ratio of 3.82 is 33% below median its 10-year median of 5.71. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 20.80. The Medical Diagnostics & Research industry median PB Ratio is 2.03. Wuxi AppTec Co's value of 3.82 is 88.2% above this industry median. Based on the distribution chart, Wuxi AppTec Co ranks #151 out of 196 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Wuxi AppTec Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #151 out of 196 companies for PB Ratio. This places Wuxi AppTec Co in the lower half of its industry. The industry median PB Ratio is 2.03. Wuxi AppTec Co's value of 3.82 is 88.2% above this benchmark. Historically, Wuxi AppTec Co's own PB Ratio has ranged from 2.00 to 20.80 over the past decade. While the company's 10-year median is 5.71 vs. the industry median of 2.03, Wuxi AppTec Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.03, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuxi AppTec Co's current PB Ratio of 3.82 is 88.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Wuxi AppTec Co and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuxi AppTec Co's current PB Ratio is 3.82, which is 33% below median its own 10-year median of 5.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.26, compared to a current price of $15.63 — trading 38.8% above its estimated fair value. The current PB Ratio is 3.82, which is 33% below median its 10-year median of 5.71 and 88.2% above the Medical Diagnostics & Research industry median of 2.03. Wuxi AppTec Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current PB Ratio is 3.82 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?
Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued.
The current stock price of $15.63 is trading 38.8% above its estimated GF Value™ of $11.26.
GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.
Key valuation signals for WUXIF:
PB Ratio: 3.82 (33% below median its 10-year median of 5.71)
GF Value™: $11.26 vs. price of $15.63 (38.8% above fair value)
Industry Position: 88.2% above the Medical Diagnostics & Research median (#151 of 196)
No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
84GF Score
Get the complete analysis for WUXIF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WUXIF has been successfully added to your 
